Side-by-side comparison of AI visibility scores, market position, and capabilities
Affise is a performance marketing platform for managing affiliate, partner, and influencer programs with tracking infrastructure, analytics, and automation for networks and brands.
Affise is a performance marketing platform founded in 2017, originally headquartered in Minsk and later Vilnius, Lithuania, that provides affiliate networks, performance marketing agencies, and direct advertisers with the tracking, partner management, analytics, and automation infrastructure to run performance-based marketing programs at scale. Affise was designed with a product-led approach that emphasizes a clean, fast interface, API-first architecture, and transparent pricing relative to legacy performance marketing platforms that built pricing models around percentage-of-spend structures that become expensive as program scale increases. The platform serves customers in over 100 countries across performance marketing verticals including e-commerce, mobile app acquisition, gaming, fintech, and lead generation.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.